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ABSTRACT
Objectives: The objective of the study was to retrospectively evaluate the density of vessels exhibiting positive glycopro-
tein CD34 expression in the uterine leiomyosarcoma tissues and their correlation with the age of patients at the time of 
tumor diagnosis.
Material and methods: The archival paraffin blocks with the cancer tissues collected from 50 patients suffering from uterine 
leiomyosarcoma were used together with their clinical and demographic data. The immunohistochemical peroxidase-de-
pendent methods were used to detect microvessels with positive CD34 expression. The glycoprotein CD34 expression was 
evaluated as a density of microvessel showing the positive immunohistochemical reaction (MVDCD34). 
Results: The negative, statistically significant correlation between the age of patients (at the moment diagnosis) and the 
MVDCD34+ (R = –0.289, p = 0.042) was found.
Conclusions: The study’s findings may suggest that the tissues of younger people constitute a permissive environment 
for pro-angiogenic factors. 
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INTRODUCTION
The components necessary for the proper function-
ing of cells are able to diffuse only to a very limited area 
around blood vessels, therefore, it is necessary virtually in 
all tissues of the body to have a suitably dense network of 
vessels. The cells with high metabolism such as cancer cells, 
require continuous supply of reactants and the discharge 
of metabolic products for their development. Therefore, 
the formation of new blood vessels is necessary for the 
development of tumors [1].
The process of angiogenesis is a subject of complex 
regulation, and its intensity depends on the established 
balance between pro-angiogenic and anti-angiogenic fac-
tors. Many substances influencing this process have been 
described, but the complexity of the relationships between 
them, their effect on the density of each of the cell surface 
receptors involved in angiogenesis and the expression of 
their genetic material, make the process of angiogenesis 
still not fully explored. It should be noted that the formation 
of tumor vessels to some degree is a subject to systemic 
regulation as well as to the influence of the tumor itself, 
therefore all-encompassing knowledge of this problem is 
particularly difficult to obtain. 
While discussing the process of tumor angiogenesis, it is 
worth to note that the formed vessels do not often have the 
proper structure and are characterized by abnormal space 
structure, (tumor cells build into their walls). Moreover, the 
cells building these vessels (endothelial cells, pericytes) 
often do not fully develop a phenotype characteristic of 
these cells in normal vessels. Taking into account the fact 
that one of the major factors activating the process of tu-
mor angiogenesis is hypoxia, abnormal structure and thus 
the function of tumor blood vessels leads to a secondary 
activation of pro-angiogenic factors, which in turn induces 
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a chaotic vasculature formation and transient ischemia 
within tumors [3].
Uterine sarcomas are relatively rare uterine tumors of 
mesenchymal origin. The biology of sarcomas differs con-
siderably from the much better-known biology of tumors 
of epithelial origin. This fact seems to be responsible for the 
limited efficacy of the cancer therapeutic methods in this 
group which have proven effective in other cancers.
The CD34 (the alternative names: HPCA1, gp105-120) 
is a transmembrane glycoprotein of a molecular weight of 
67kDa, occurring e.g. on endothelial cells. Apart from the 
endothelium, it occurs physiologically on the surface of 
hematopoietic cells, stem cells, osteoclasts, the precursor 
cells of B and T lymphocytes. Moreover, CD34+ was also 
found in some cancers such as lymphoblastic leukemia, 
gastrointestinal stromal tumors (GIST), Kaposi’s sarcoma, 
vascular tumors [4]. The role of glycoprotein CD34 is not 
fully understood, it is believed, however, that it plays a role 
in the process of adhesion and cell migration.
The presence of the CD34 glycoprotein on the surface 
of endothelial cells allows its use as a marker for the pres-
ence of these cells in tissues and thereby an assessment the 
vascularity of the examined tissues [2, 5]. Currently, besides 
such proteins as CD105, CD31, vWF, VII factor is one of the 
most frequently used markers in the assessment of blood 
vessel density. Many studies have demonstrated its high 
sensitivity and specificity in the evaluation of microvessel 
density (MVD). Apart from the CD34+ vessel density, the 
microvessel area parameter (MVA) is used as the percent-
age of the area of the CD34+ cells in the visual field. In the 
studies carried out in renal cancer, the superiority of vessels 
density evaluation with the use of CD34 in comparison 
to CD31 was found. Moreover, the correlation between 
MVDCD34+, the histological type of tumor and the time of 
the overall survival of patients was shown. The evaluation 
of MVD with the use of antibodies targeted against glyco-
protein CD34 is possible in the light microscope and due to 
the numerous studies conducted in this way, the obtained 
results can be compared. It is significant from the point of 
view of results comparability that MVDCD34+ is defined as 
an absolute value, i.e. the number of vessels showing the 
color reaction in mm2 [6].
OBJECTIVES
The aim of the study is to retrospectively evaluate the 
density of vessels exhibiting positive glycoprotein CD34 ex-
pression in the uterine leiomyosarcoma tissues and their cor-
relation with the age of patients at the time of tumor diagnosis.
MATERIAL AND METHODS
The study group comprised of 50 patients with the dia- 
gnosis of the uterine leiomyosarcoma who were operated 
in the 1st Chair and Department of Gynecological Onco- 
logy and Gynecology of the Medical University of Lublin in 
2000–2013. The histology of all of cases was leiomyosarcoma, 
slides were assessed by two independent, well experienced 
pathologists who confirmed primary diagnosis. 33 (66%) 
patients enrolled to the study were on FIGO I stage, 6 (12%), 
5 (10%), 6 (12%) patients were on FIGO II, III and IV respectively.
In the studies, the archival paraffin blocks with the cancer 
tissues were used together with the clinical and demographic 
data of patients. The immunohistochemical peroxidase-de-
pendent methods were used. The primary antibody Mono-
clonal Mouse anti human CD34 Class II Clone QBEnd10 was 
used as marker together with the secondary antibody Dako 
EnVision+System- HRPLabelled Polymer Anti Mouse. The 
staining was conducted according to the guidance of anti-
bodies’ manufacturer. Positive control was performed by ob-
taining color reaction with primary antibody against CD34 in 
the tissue of human tonsil (according to recommendations of 
manufacturer). Negative control was performed by applying 
the protocol without primary antibody in LMS tissue.
The glycoprotein CD34 expression was evaluated as 
a density of microvessel showing the positive immunohis-
tochemical reaction (MVDCD34). The evaluation was made 
with the use of the light microscope at 200× magnification 
in ten fields of view (hot spot), which corresponds to the mi-
crovessel density in the area of 20 × 0.7850 mm2 = 15.7 mm2.
The correlations between variables were evaluated with 
the Spearman’s test.
RESULTS
The patients average age was 52.84 (median 51.50, SD 
12.36, min. 29 years old, max. 76 years old). For purposes 
of statistical analysis patients were divided into 3 groups 
depending on their age at cancer diagnosis. Group I — un-
der 50 years old (21 patients), group II — 50–70 years old 
(21 patients), group III — over 70 years old (8 patients).
In all studied tumors, the presence of CD34+ vessels 
was found. While analyzing the correlation between the 
examined variables, the negative, statistically significant 
correlation between the age of patients (at the moment of 
diagnosis) and the CD34+ microvessel density (MVDCD34+): 
R = –0.289, p = 0.042 was found (Fig. 1). No significant cor-
relation was found between stage of clinical advancement 
(according to FIGO) and MVDCD34+.
DISCUSSION
While discussing the obtained results of correlation be-
tween CD34+ vessel density and the age of patients at the 
moment of diagnosis, the negative, statistically significant 
correlation is crucial. In most available comparative stud-
ies, the authors scheduling the selection of groups tend 
to yield a maximum of similarity with respect to demo-
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graphic features, therefore such observations are rarely 
presented in reports. From this point of view, the results of 
some basic research appear to be interesting. Reed et al. 
reported significantly lower vessel density in cell cultures 
of malignant melanoma and prostate carcinoma implanted 
subcutaneously in older than younger mice [7]. Moreover, 
Sadoun et al. showed significant, age-dependant differ-
ences in expression of TGF-beta1, VEGF and TSP-2 within 
the implanted tumors [8].
The negative correlation between the age of patients 
with osteosarcoma and the vessel density within the tu-
mor was also observed by Kubo et al. [9]. The results of 
the described studies seem to suggest that the tissues in 
younger people constitute a permissive environment for 
pro-angiogenic factors. Therefore, the perspective of the 
expression evaluation of the extracellular factors regulating 
angiogenesis such as metalloproteinases, cyclooxygenase, 
or nitric oxide synthase in uterine sarcoma and their correla-
tion with the age of patients seem to be interesting. Such 
observations could contribute to works on the introduction 
of individualized therapy of these tumors. It may in fact turn 
out that some substances currently used in experimental 
cancer therapy may have a particular activity in selected pa-
tients, e.g. in younger patients or in cases of tumors present-
ing overexpression of selected pro-angiogenic factors. Tak-
ing into account the potential role of extracellular factors 
that activate the process of angiogenesis, some hopes are 
drawn to the metalloproteinase inhibitors implementation. 
The evaluation of the metalloproteinases and their inhibi-
tors activity in LMS together with the results concerning the 
vessel density have a chance to complete substantially the 
understanding of the mechanisms that ensure perfusion in 
tumors. It should also be noticed that the results obtained in 
this way could contribute to planning the experimental re-
search with the use of new, targeted therapies. Starting from 
the well documented assumption that the tumor growth is 
dependent on the development of the vasculature, showing 
the correlation between the age of patients and the vessel 
density in tumors that were diagnosed can, in some way, 
correspond to the differences observed in some cancers 
concerning the dynamics of tumor growth depending on 
the age of a patient. Such kind of studies were conducted 
in breast or thyroid cancer [10–12].
CONCLUSIONS
The statistically significant, negative correlation was 
found between the CD34+ vessel density and the age of 
patients at the moment of a diagnosis. It might suggest 
that the tissues of younger people constitute a permissive 
environment for pro-angiogenic factors. 
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Figure 1. CD34+ microvessels density and patients age in uterine 
sarcoma (presented as median (white, horizontal line), 25 percentile 
(lower quartile), 75 percentile (upper quartile) and outliers)
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